Evidence map›Paper›PMID 39177652›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society.

Katja Zeppenfeld, Robert Rademaker, Amin Al-Ahmad, Corrado Carbucicchio, Christian De Chillou, Jakub Cvek, Micaela Ebert, Gordon Ho, Josef Kautzner, Pier Lambiase and 17 more

Registry-linked trialAbstract readConsensus Statement
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06769451 (Radiosurgery With proTOns for the Treatment of VEntricular maLignant Tachyarrhytmias), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06769451 nanot yet recruitingnot on this map

Radiosurgery With proTOns for the Treatment of VEntricular maLignant Tachyarrhytmias (TOVEL Study)

TypeinterventionalSponsorAzienda Sanitaria Universitaria Integrata del TrentinoRan2025 to 2030Enrolled21ConditionsVentricular Arrhythmia, Ventricular Tachycardia (V-Tach)ArmsStereotactic Arrhythmia Radioablation (STAR) with Proton Therapy
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  2. Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Pooled it
  3. Development of a prospective clinical workflow for proton beam therapy of ventricular tachycardia.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. AI-Based QRS Onset Detection in the Early Ventricular Activation Site ECGs.IEEE journal of biomedical and health informatics · 2026
    Article
  12. Stereotactic radioablation for ventricular tachycardia in patients untreatable by catheter ablation: evidence of efficacy, safety, and impact on coronary arteries.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  13. Review
  14. Review
  15. Rethinking imaging protocols, training models, and target delineation in cardiac radioablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  16. Excellent interobserver agreement and steep learning curve for target volume delineation for stereotactic arrhythmia radioablation using a commercial software.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  17. Article
  18. A new application of computed tomography: stereotactic radiotherapy in the treatment of ventricular arrhythmias.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  19. Ventricular tachycardia functional substrate targeting: a standalone strategy for all?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Katja ZeppenfeldDepartment of Cardiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
Robert RademakerDepartment of Cardiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.ORCID 0000-0002-1599-1535
Amin Al-AhmadElectrophysiology, Texas Cardiac Arrhythmia Institute, Austin, TX, USA.ORCID 0000-0002-8547-025X
Corrado CarbucicchioDepartment of Arrhythmology, Centro Cardiologico Monzino IRCCS, Milan, Italy.ORCID 0000-0001-5954-537X
Christian De ChillouCHU de Nancy, Cardiology, Institut Lorrain du Coeur et des Vaisseaux, Vandoeuvre Les Nancy, France.ORCID 0000-0002-9025-6821
Jakub CvekRadiation Oncology, University of Ostrava, Ostrava, Czech Republic.
Micaela EbertElectrophysiology, Heart Center Leipzig, Leipzig, Germany.ORCID 0000-0002-3480-5013
Gordon HoDivision of Cardiology, Section of Cardiac Electrophysiology, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-6467-3333
Josef KautznerCardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.ORCID 0000-0002-1632-6182
Pier LambiaseCardiology Department, University College London, London, UK.ORCID 0000-0002-9055-9267
Jose Luis MerinoCardiology, Hospital General La Paz, Madrid, Spain.ORCID 0000-0002-1737-1903
Michael LloydEmory Electrophysiology, Electrophysiology Lab Director, EUH, Emory University Hospital, Atlanta, GA, USA.ORCID 0000-0002-0708-9330
Satish MisraAtrium Health Sanger Heart Vascular Institute Kenilworth, Charlotte, NC, USA.
Etienne PruvotDepartment of Cardiology, Lausanne University Hospital, CHUV, Lausanne, Switzerland.ORCID 0000-0003-1386-9285
John SappQEII Health Sciences Center, Halifax Infirmary Site, Halifax, NS, Canada.ORCID 0000-0002-9602-2751
Luis SchiappacasseDepartment of Cardiology, Service de Radio-Oncologie, Lausanne University Hospital, CHUV, Lausanne, Switzerland.ORCID 0000-0001-7621-1662
Marek SramkoCardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
William G StevensonVanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-2118-7893
Paul C ZeiProfessor of Medicine, Cardiac Electrophysiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dan WichterleCardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Jonathan ChrispinAssistant Professor of Medicine, Johns Hopkins Medicine Division of Cardiology, Baltimore, MD, USA.
Claudia Herrera SiklodyInselspital, Hôpital universitaire de Berne, Bern, Switzerland.
Radek NeuwirthFaculty of Medicine, Masaryk University, Brno, Czech Republic.
Gemma PelargonioCardiology Department, Policlinico Gemelli, Rome, Italy.
Tobias ReichlinDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Clifford RobinsonDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Claudio TondoDepartment of Clinical Electrophysiology and Pacing, Monzino Cardiac Center, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereotactic arrhythmia radioablation (STAR) is a novel, non-invasive, and promising treatment option for ventricular arrhythmias (VAs). It has been applied in highly selected patients mainly as bailout procedure, when (multiple) catheter ablations, together with anti-arrhythmic drugs, were unable to control the VAs. Despite the increasing clinical use, there is still limited knowledge of the acute and long-term response of normal and diseased myocardium to STAR. Acute toxicity appeared to be reasonably low, but potential late adverse effects may be underreported. Among published studies, the provided methodological information is often limited, and patient selection, target volume definition, methods for determination and transfer of target volume, and techniques for treatment planning and execution differ across studies, hampering the pooling of data and comparison across studies. In addition, STAR requires close and new collaboration between clinical electrophysiologists and radiation oncologists, which is facilitated by shared knowledge in each collaborator's area of expertise and a common language. This clinical consensus statement provides uniform definition of cardiac target volumes. It aims to provide advice in patient selection for STAR including aetiology-specific aspects and advice in optimal cardiac target volume identification based on available evidence. Safety concerns and the advice for acute and long-term monitoring including the importance of standardized reporting and follow-up are covered by this document. Areas of uncertainty are listed, which require high-quality, reliable pre-clinical and clinical evidence before the expansion of STAR beyond clinical scenarios in which proven therapies are ineffective or unavailable.

Indexed as

CardiologyPatient SelectionRadiosurgeryTachycardia, VentricularAction PotentialsEuropeHumansRisk FactorsTreatment OutcomeAblationRadiotherapyStereotactic arrhythmia radioablation (STAR)Sudden deathVentricular tachycardia

Identifiers

PMID39177652
PMCPMC12041921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.